Thapsigargin and withaferin share 8 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.267 means 27% of the combined target set is bound by both compounds. The IDF-weighted score of 0.210 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Thapsigargin and withaferin have in common?
Thapsigargin and withaferin share 8 molecular targets with a Jaccard similarity of 27%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Thapsigargin and withaferin be combined?
Thapsigargin and withaferin share 8 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Thapsigargin or withaferin?
Both Thapsigargin and withaferin have substantial PubMed research. View their individual profiles for full evidence scores.